Luteolin: A Potential Multiple Targeted Drug Effectively Inhibits Diabetes Mellitus Protein Targets
Rakesh Davella, Estari Mamidala
Journal of Pharmaceutical Research International · pp. 161–171 · Published 22 Sep 2021
10.9734/jpri/2021/v33i44B32661Abstract
Background: Diabetes is a significant health problem that has reached worrisome proportions: almost half of the world's population now has diabetes. Diabetes mellitus, or diabetes, is a severe, long-term disease in which a person's blood glucose levels are elevated due to their body's inability to make any or enough insulin, or to properly utilise the insulin that it does produce. The chemicals extracted from medicinal plants were shown to be both safer and more bioactive than manufactured medicines. Objective: The goal of this research was to use molecular docking to find possible binding affinities of luteolin, a phytocompound from Rumex vesicarius L, to five target proteins, in order to find the lead molecule against diabetes. Methodology: One chemical was isolated from Rumex vesicarius L. leaves in this research. The binding affinity of the complexes was calculated using molecular docking studies. The docking procedure was carried out using AutoDock Tools 1.5.6, which brought the ligand together with the target proteins. Results: The binding energies of Luteolin with major Glutamine-fructose-6-phosphate amido transferase (GFAT1), Pancreatic α-Amylase, Forkhead box protein O1(FOX01), α--glucosidase, and Dipeptidyl peptidase-4 (DPP-4) were determined to be -6.89, -6.80, -6.36, -9.35, and -7.72 kcal. Conclusion: Our findings suggest that luteolin can target not only α--glucosidase but also DPP4 and other targets, suggesting that they may be used as type 2 diabetes mellitus inhibitors. We believe that this phytochemical, luteolin, may be utilised in preclinical studies as an anti-diabetic drug to combat diabetes mellitus.
Cited by 16
Aparna Chaudhuri, Bidyut Bandyopadhyay, Buddhadev Mondal · In Silico Pharmacology · 2025
Akanksha, Neeraj Kumar, Mohd Aqil · Chemistry & Biodiversity · 2025
Jamie McMillan, Megan Jean Bester, Zeno Apostolides · In Silico Pharmacology · 2025
Mahwish, Muhammad Imran, Hammad Naeem · Food Science & Nutrition · 2025
Premalatha B. R, Suman Basavaraju, SubbaRao V. Madhunapantula · Biomedical and Pharmacology Journal · 2024
Hamza Mohammad Assaggaf · International Journal of Biological Macromolecules · 2025
Deepak Kumar, Raushan Kumar Jha, Prasun Choudhary · Discover Chemistry · 2025
Nandakumar Muruganathan, Anand Raj Dhanapal, Venkidasamy Baskar · Metabolites · 2022
Anjaly Babu, D. Rakesh, P. Supraja · Results in Surfaces and Interfaces · 2022
Rakesh Davella, V. Ravinder Reddy, Shivakrishna Pujala · International journal of health sciences · 2022
Showing 15 of 16 known citations — external sources report more than can currently be individually listed.
Related research
- Metal Based α-glucosidase Inhibitors: Synthesis, Characterization and α-glucosidase Inhibition Activity of Transition Metal Complexes — shares topic coverage
- Effect of Natural Products on Some Glycosidases and Their Expected Hypoglycemic Potential — shares topic coverage
- Synthesis, Characterization and α- Glucosidase Inhibition of Some Copper, Cobalt, Nickel and Zinc Complexes with N – Methylethylenediamine — shares topic coverage
- α-Glucosidase Inhibition and Glycemic Index of Chocolate Incorporated with Selected Spices — shares topic coverage
- Anti-Diabetic Activities of the Extracts from Euphorbia hirta L. (Euphorbiaceae) Specie found in Burkina Faso Using α-Glucosidase Inhibitor — shares topic coverage
Article metrics
Real usage data collected on this platform.
7
Page views
0
PDF downloads
0
Outbound clicks
16
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.